Corentec Co., Ltd. announced that it expects to receive KRW 9.99999474 billion in funding
July 24, 2019
Share
Corentec Co., Ltd. (KOSDAQ:A104540) announced a private placement of 1,776,198 common shares of par value KRW 500 at KRW 5,630 per share for gross proceeds of KRW 9,999,994,740 on July 25, 2019. The transaction will include participation from SHI for 90,000 shares, Dual use won for 49,360 shares, Lee Kyu-eun for 5,330 shares, Misan cooperation for 53,280 shares, and other investors. The company will issue shares through third-party assignment. The common shares have a lock up period of 12 months. The transaction has been approved by the board of directors of the company. The transaction is expected to close on August 1, 2019.
Corentec Co., Ltd. is a Korea-based company engaged in the development, manufacture and sale of orthopedic implants. The Companyâs products consist of hip products, including primary systems, hemi-arthroplasty systems and revision systems, such as cementless femoral stems, cemented femoral stems, cups for acetabular systems, bearing systems and others; knee products, including primary knee system fixed type, primary knee system mobile type, revision knee systems and augments systems, and spine products, including pedicle screws and peek cages. The Company mainly provides its hip products under the brand name of BENCOX, knee products under the brand name of LOSPA and spine products under the brand name of LOSPA IS. The Company distributes its products within domestic market and to overseas markets.
CORENTEC CO., LTD. 
